Gene Symbol | Gene ID | Gene Info |
---|---|---|
Ybx1
|
ENSMUSG00000028639.8 | Y box protein 1 |
Nfya
|
ENSMUSG00000023994.7 | nuclear transcription factor-Y alpha |
Nfyb
|
ENSMUSG00000020248.12 | nuclear transcription factor-Y beta |
Nfyc
|
ENSMUSG00000032897.11 | nuclear transcription factor-Y gamma |
Cebpz
|
ENSMUSG00000024081.8 | CCAAT/enhancer binding protein zeta |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr17_78936445_78936974 | Cebpz | 328 | 0.547778 | 0.32 | 1.3e-02 | Click! |
chr17_78933948_78934111 | Cebpz | 3008 | 0.157961 | -0.25 | 5.2e-02 | Click! |
chr17_78934472_78934623 | Cebpz | 2490 | 0.174397 | -0.19 | 1.5e-01 | Click! |
chr17_78934273_78934424 | Cebpz | 2689 | 0.167180 | -0.17 | 2.1e-01 | Click! |
chr17_78935327_78935688 | Cebpz | 1530 | 0.241263 | -0.13 | 3.0e-01 | Click! |
chr17_48408325_48409561 | Nfya | 745 | 0.420078 | 0.20 | 1.3e-01 | Click! |
chr17_48408110_48408286 | Nfya | 1490 | 0.238172 | -0.14 | 2.8e-01 | Click! |
chr17_48406750_48406901 | Nfya | 2863 | 0.151421 | -0.14 | 3.0e-01 | Click! |
chr17_48405176_48405327 | Nfya | 4437 | 0.127268 | 0.12 | 3.6e-01 | Click! |
chr17_48407628_48407779 | Nfya | 1985 | 0.190303 | -0.12 | 3.6e-01 | Click! |
chr10_82760283_82761261 | Nfyb | 2874 | 0.172793 | 0.61 | 2.0e-07 | Click! |
chr10_82764298_82764636 | Nfyb | 323 | 0.827476 | 0.50 | 4.0e-05 | Click! |
chr10_82761262_82761758 | Nfyb | 2136 | 0.210927 | 0.50 | 4.9e-05 | Click! |
chr10_82762742_82763996 | Nfyb | 277 | 0.860428 | 0.35 | 6.3e-03 | Click! |
chr10_82758371_82758522 | Nfyb | 1139 | 0.376009 | 0.15 | 2.5e-01 | Click! |
chr4_120825823_120825990 | Nfyc | 199 | 0.908378 | 0.68 | 1.7e-09 | Click! |
chr4_120815076_120815709 | Nfyc | 320 | 0.834292 | 0.54 | 9.9e-06 | Click! |
chr4_120815888_120816094 | Nfyc | 279 | 0.861768 | 0.53 | 1.2e-05 | Click! |
chr4_120816672_120816895 | Nfyc | 1071 | 0.397502 | -0.46 | 2.0e-04 | Click! |
chr4_120824633_120825182 | Nfyc | 777 | 0.525423 | 0.36 | 4.2e-03 | Click! |
chr4_119294797_119295122 | Ybx1 | 355 | 0.540598 | 0.53 | 1.1e-05 | Click! |
chr4_119292719_119293132 | Ybx1 | 1555 | 0.206445 | 0.33 | 9.9e-03 | Click! |
chr4_119284636_119284927 | Ybx1 | 1989 | 0.168963 | -0.29 | 2.5e-02 | Click! |
chr4_119291834_119291985 | Ybx1 | 2571 | 0.136553 | 0.28 | 3.3e-02 | Click! |
chr4_119281835_119281986 | Ybx1 | 276 | 0.815050 | -0.23 | 8.0e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr15_82255980_82257145 | 13.36 |
1500009C09Rik |
RIKEN cDNA 1500009C09 gene |
539 |
0.56 |
chr13_20472918_20473069 | 10.97 |
Elmo1 |
engulfment and cell motility 1 |
267 |
0.69 |
chr5_137553079_137554278 | 10.57 |
Actl6b |
actin-like 6B |
121 |
0.89 |
chr18_50034808_50035376 | 9.86 |
Tnfaip8 |
tumor necrosis factor, alpha-induced protein 8 |
4063 |
0.24 |
chr4_5724213_5725550 | 9.80 |
Fam110b |
family with sequence similarity 110, member B |
569 |
0.81 |
chr4_17856811_17857094 | 9.48 |
Mmp16 |
matrix metallopeptidase 16 |
3359 |
0.38 |
chr5_70842167_70842810 | 7.92 |
Gabrg1 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 1 |
129 |
0.98 |
chr11_32002849_32003000 | 7.36 |
Nsg2 |
neuron specific gene family member 2 |
2422 |
0.32 |
chr10_109011001_109011929 | 7.04 |
Syt1 |
synaptotagmin I |
483 |
0.88 |
chr10_81229656_81230911 | 6.96 |
Atcay |
ataxia, cerebellar, Cayman type |
502 |
0.53 |
chr13_48497785_48498324 | 6.95 |
Zfp169 |
zinc finger protein 169 |
8885 |
0.11 |
chr4_110287512_110287903 | 6.95 |
Elavl4 |
ELAV like RNA binding protein 4 |
180 |
0.97 |
chr8_45507516_45508498 | 6.85 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
89 |
0.97 |
chr4_133479632_133480107 | 6.84 |
Tent5b |
terminal nucleotidyltransferase 5B |
263 |
0.85 |
chr10_80298461_80300404 | 6.83 |
Apc2 |
APC regulator of WNT signaling pathway 2 |
341 |
0.69 |
chr15_81938273_81938633 | 6.62 |
Csdc2 |
cold shock domain containing C2, RNA binding |
1471 |
0.22 |
chr7_19175632_19177533 | 6.62 |
Eml2 |
echinoderm microtubule associated protein like 2 |
161 |
0.88 |
chr7_30599583_30600852 | 6.46 |
Zbtb32 |
zinc finger and BTB domain containing 32 |
1308 |
0.17 |
chr14_121446770_121447376 | 6.39 |
Gm33299 |
predicted gene, 33299 |
8689 |
0.19 |
chr4_109343931_109344459 | 6.29 |
Eps15 |
epidermal growth factor receptor pathway substrate 15 |
942 |
0.57 |
chr19_6418703_6419936 | 6.28 |
Nrxn2 |
neurexin II |
554 |
0.44 |
chr8_111393846_111394160 | 6.25 |
Fa2h |
fatty acid 2-hydroxylase |
179 |
0.94 |
chr18_80040276_80040957 | 6.23 |
Pard6g |
par-6 family cell polarity regulator gamma |
6274 |
0.08 |
chr13_109927479_109928182 | 6.09 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
986 |
0.65 |
chr1_79450112_79451070 | 6.07 |
Scg2 |
secretogranin II |
10471 |
0.24 |
chr1_42700819_42701404 | 6.07 |
Pou3f3 |
POU domain, class 3, transcription factor 3 |
5343 |
0.14 |
chr10_80329794_80330086 | 5.91 |
Reep6 |
receptor accessory protein 6 |
13 |
0.85 |
chr1_115684558_115685809 | 5.76 |
Cntnap5a |
contactin associated protein-like 5A |
427 |
0.58 |
chr18_23036665_23037864 | 5.60 |
Nol4 |
nucleolar protein 4 |
1392 |
0.59 |
chr6_134886811_134888239 | 5.56 |
Gpr19 |
G protein-coupled receptor 19 |
243 |
0.87 |
chr2_152081612_152083149 | 5.55 |
Scrt2 |
scratch family zinc finger 2 |
851 |
0.52 |
chr6_93911862_93913573 | 5.52 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
213 |
0.95 |
chr11_57014096_57014247 | 5.51 |
Gria1 |
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
1125 |
0.68 |
chr10_127121208_127121635 | 5.47 |
Os9 |
amplified in osteosarcoma |
290 |
0.78 |
chr16_77235848_77236417 | 5.39 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
185 |
0.96 |
chr13_28416755_28419194 | 5.37 |
Gm40841 |
predicted gene, 40841 |
1889 |
0.42 |
chr4_45824039_45824548 | 5.35 |
Igfbpl1 |
insulin-like growth factor binding protein-like 1 |
2630 |
0.22 |
chr7_79507974_79509311 | 5.28 |
A330074H02Rik |
RIKEN cDNA A330074H02 gene |
1720 |
0.18 |
chr5_115432636_115432916 | 5.22 |
Msi1 |
musashi RNA-binding protein 1 |
616 |
0.49 |
chr17_69970281_69970673 | 5.21 |
Dlgap1 |
DLG associated protein 1 |
1056 |
0.6 |
chr1_169747005_169748207 | 5.20 |
Rgs4 |
regulator of G-protein signaling 4 |
17 |
0.98 |
chr3_84303363_84303817 | 5.12 |
Trim2 |
tripartite motif-containing 2 |
1151 |
0.59 |
chr7_48958571_48959910 | 5.11 |
Nav2 |
neuron navigator 2 |
143 |
0.95 |
chr2_32575113_32576098 | 5.09 |
9430097D07Rik |
RIKEN cDNA 9430097D07 gene |
79 |
0.53 |
chr4_28143186_28143619 | 5.02 |
Gm11911 |
predicted gene 11911 |
76225 |
0.11 |
chr5_125327376_125327881 | 4.97 |
Scarb1 |
scavenger receptor class B, member 1 |
91 |
0.96 |
chr1_3669608_3669968 | 4.89 |
Xkr4 |
X-linked Kx blood group related 4 |
1710 |
0.33 |
chr6_13835523_13837039 | 4.89 |
Gpr85 |
G protein-coupled receptor 85 |
960 |
0.59 |
chr5_65130636_65132102 | 4.89 |
Klhl5 |
kelch-like 5 |
34 |
0.97 |
chr2_32430451_32431664 | 4.85 |
Slc25a25 |
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25 |
47 |
0.95 |
chr8_23669376_23670424 | 4.75 |
Zmat4 |
zinc finger, matrin type 4 |
226 |
0.95 |
chr5_138275220_138276850 | 4.69 |
Gpc2 |
glypican 2 (cerebroglycan) |
2202 |
0.11 |
chr2_163438209_163439457 | 4.65 |
Gdap1l1 |
ganglioside-induced differentiation-associated protein 1-like 1 |
300 |
0.84 |
chr1_165283582_165283733 | 4.61 |
Gpr161 |
G protein-coupled receptor 161 |
12132 |
0.16 |
chrX_100767123_100768659 | 4.58 |
Dlg3 |
discs large MAGUK scaffold protein 3 |
104 |
0.96 |
chr1_35869391_35870207 | 4.51 |
1110002O04Rik |
RIKEN cDNA 1110002O04 gene |
10046 |
0.21 |
chr17_83267468_83267914 | 4.51 |
Gm24240 |
predicted gene, 24240 |
2280 |
0.31 |
chr4_127989836_127989987 | 4.50 |
Csmd2 |
CUB and Sushi multiple domains 2 |
1867 |
0.41 |
chr9_121285962_121286402 | 4.48 |
Gm34655 |
predicted gene, 34655 |
8406 |
0.14 |
chr4_129440058_129441358 | 4.48 |
Zbtb8b |
zinc finger and BTB domain containing 8b |
110 |
0.94 |
chr9_108824114_108825614 | 4.43 |
Gm35025 |
predicted gene, 35025 |
3 |
0.87 |
chr8_63951776_63952541 | 4.42 |
Sgo2b |
shugoshin 2B |
12 |
0.98 |
chr11_60141098_60141590 | 4.41 |
Rai1 |
retinoic acid induced 1 |
1085 |
0.44 |
chr19_47015573_47015946 | 4.39 |
Nt5c2 |
5'-nucleotidase, cytosolic II |
606 |
0.53 |
chr7_25004827_25006284 | 4.37 |
Atp1a3 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
340 |
0.79 |
chr9_14276077_14276228 | 4.35 |
Sesn3 |
sestrin 3 |
149 |
0.94 |
chr9_10903843_10905236 | 4.35 |
Cntn5 |
contactin 5 |
90 |
0.65 |
chr14_69190219_69191353 | 4.35 |
Nkx3-1 |
NK3 homeobox 1 |
148 |
0.93 |
chr4_106606790_106607408 | 4.33 |
Lexm |
lymphocyte expansion molecule |
296 |
0.84 |
chr2_127559243_127559747 | 4.27 |
Gm14229 |
predicted gene 14229 |
9931 |
0.12 |
chr11_87759834_87761999 | 4.26 |
Tspoap1 |
TSPO associated protein 1 |
329 |
0.75 |
chr3_88208231_88208654 | 4.23 |
Gm3764 |
predicted gene 3764 |
1030 |
0.28 |
chr17_56241459_56242409 | 4.21 |
A230051N06Rik |
RIKEN cDNA A230051N06 gene |
218 |
0.81 |
chr13_105444000_105445296 | 4.19 |
Htr1a |
5-hydroxytryptamine (serotonin) receptor 1A |
1009 |
0.69 |
chr10_87485570_87486803 | 4.18 |
Ascl1 |
achaete-scute family bHLH transcription factor 1 |
7474 |
0.2 |
chr5_107498769_107499247 | 4.18 |
Btbd8 |
BTB (POZ) domain containing 8 |
1229 |
0.33 |
chr7_61940119_61940573 | 4.15 |
Mir344-2 |
microRNA 344-2 |
240 |
0.87 |
chr5_92042274_92042778 | 4.13 |
Cdkl2 |
cyclin-dependent kinase-like 2 (CDC2-related kinase) |
146 |
0.94 |
chr4_32241680_32242499 | 4.12 |
Bach2 |
BTB and CNC homology, basic leucine zipper transcription factor 2 |
3012 |
0.26 |
chr13_85164740_85164914 | 4.12 |
Gm47746 |
predicted gene, 47746 |
24107 |
0.15 |
chr15_92160888_92162023 | 4.12 |
Cntn1 |
contactin 1 |
98 |
0.98 |
chr5_113643191_113643763 | 4.10 |
Cmklr1 |
chemokine-like receptor 1 |
126 |
0.94 |
chr7_127208929_127209633 | 4.04 |
Mylpf |
myosin light chain, phosphorylatable, fast skeletal muscle |
382 |
0.58 |
chr17_69969717_69970050 | 4.03 |
Dlgap1 |
DLG associated protein 1 |
462 |
0.86 |
chr11_81968072_81969328 | 4.02 |
Asic2 |
acid-sensing (proton-gated) ion channel 2 |
243 |
0.91 |
chr11_104157433_104158124 | 4.01 |
Crhr1 |
corticotropin releasing hormone receptor 1 |
24923 |
0.16 |
chr17_56078744_56079399 | 4.00 |
Hdgfl2 |
HDGF like 2 |
563 |
0.56 |
chr6_145045024_145045326 | 3.98 |
Gm26666 |
predicted gene, 26666 |
2384 |
0.2 |
chr7_140821505_140822346 | 3.98 |
Zfp941 |
zinc finger protein 941 |
207 |
0.83 |
chr8_123413418_123414506 | 3.95 |
Tubb3 |
tubulin, beta 3 class III |
2372 |
0.11 |
chr1_132739329_132739734 | 3.93 |
Nfasc |
neurofascin |
2226 |
0.31 |
chr8_108536302_108537095 | 3.90 |
Gm39244 |
predicted gene, 39244 |
249 |
0.95 |
chr10_89256685_89257951 | 3.90 |
Ano4 |
anoctamin 4 |
18 |
0.99 |
chr4_128688959_128689777 | 3.87 |
Phc2 |
polyhomeotic 2 |
573 |
0.76 |
chr13_55484574_55485692 | 3.83 |
Dbn1 |
drebrin 1 |
1164 |
0.26 |
chr1_51922994_51923259 | 3.82 |
Myo1b |
myosin IB |
7055 |
0.14 |
chr3_28176114_28177040 | 3.81 |
Gm42196 |
predicted gene, 42196 |
24 |
0.98 |
chr4_42953037_42954334 | 3.79 |
Dnajb5 |
DnaJ heat shock protein family (Hsp40) member B5 |
591 |
0.62 |
chr12_75389703_75390099 | 3.73 |
Gphb5 |
glycoprotein hormone beta 5 |
26880 |
0.22 |
chr3_88214322_88216234 | 3.73 |
Mir3093 |
microRNA 3093 |
107 |
0.63 |
chr4_122998435_122998747 | 3.67 |
Mycl |
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived |
289 |
0.87 |
chr1_42695663_42696087 | 3.67 |
Pou3f3 |
POU domain, class 3, transcription factor 3 |
107 |
0.9 |
chr1_158354059_158354432 | 3.66 |
Brinp2 |
bone morphogenic protein/retinoic acid inducible neural-specific 2 |
1984 |
0.33 |
chr4_141010412_141011785 | 3.65 |
Mfap2 |
microfibrillar-associated protein 2 |
454 |
0.71 |
chr6_119105635_119105786 | 3.65 |
Cacna1c |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
2265 |
0.41 |
chr7_61311164_61311772 | 3.63 |
A230006K03Rik |
RIKEN cDNA A230006K03 gene |
245 |
0.96 |
chr10_111247804_111248910 | 3.63 |
Osbpl8 |
oxysterol binding protein-like 8 |
289 |
0.91 |
chr1_158355408_158356664 | 3.63 |
Brinp2 |
bone morphogenic protein/retinoic acid inducible neural-specific 2 |
193 |
0.95 |
chr11_116725061_116725491 | 3.63 |
Gm11735 |
predicted gene 11735 |
24557 |
0.08 |
chr18_34249368_34249586 | 3.62 |
Apc |
APC, WNT signaling pathway regulator |
1779 |
0.35 |
chr9_113811975_113812935 | 3.60 |
Clasp2 |
CLIP associating protein 2 |
131 |
0.97 |
chr1_41604694_41605241 | 3.58 |
Gm28634 |
predicted gene 28634 |
75424 |
0.12 |
chr1_99772154_99773556 | 3.58 |
Cntnap5b |
contactin associated protein-like 5B |
90 |
0.98 |
chr4_119492603_119492890 | 3.57 |
Rimkla |
ribosomal modification protein rimK-like family member A |
118 |
0.92 |
chr12_85150310_85151505 | 3.57 |
Rps6kl1 |
ribosomal protein S6 kinase-like 1 |
329 |
0.81 |
chrX_73879886_73880799 | 3.56 |
L1cam |
L1 cell adhesion molecule |
453 |
0.7 |
chr12_31713469_31714088 | 3.55 |
Gpr22 |
G protein-coupled receptor 22 |
148 |
0.95 |
chr6_82774523_82774771 | 3.55 |
Hk2 |
hexokinase 2 |
193 |
0.92 |
chr2_174917379_174917852 | 3.54 |
Gm14616 |
predicted gene 14616 |
61326 |
0.09 |
chrX_136992581_136994028 | 3.54 |
Zcchc18 |
zinc finger, CCHC domain containing 18 |
6 |
0.72 |
chr6_90809120_90810568 | 3.52 |
Iqsec1 |
IQ motif and Sec7 domain 1 |
279 |
0.89 |
chr10_116017652_116019652 | 3.51 |
Ptprr |
protein tyrosine phosphatase, receptor type, R |
365 |
0.92 |
chr4_45825879_45827166 | 3.50 |
Igfbpl1 |
insulin-like growth factor binding protein-like 1 |
401 |
0.81 |
chr7_61054918_61055468 | 3.49 |
Gm38451 |
predicted gene, 38451 |
75491 |
0.11 |
chr15_92050857_92052193 | 3.48 |
Cntn1 |
contactin 1 |
360 |
0.9 |
chr15_20448699_20449797 | 3.47 |
Cdh12 |
cadherin 12 |
17 |
0.53 |
chrX_96712746_96713886 | 3.44 |
Gpr165 |
G protein-coupled receptor 165 |
125 |
0.98 |
chr6_119328752_119331284 | 3.44 |
Lrtm2 |
leucine-rich repeats and transmembrane domains 2 |
739 |
0.43 |
chr10_102158656_102159350 | 3.43 |
Mgat4c |
MGAT4 family, member C |
76 |
0.99 |
chr14_13283913_13285295 | 3.41 |
Gm5087 |
predicted gene 5087 |
26 |
0.69 |
chr15_23035608_23036941 | 3.40 |
Cdh18 |
cadherin 18 |
181 |
0.97 |
chr18_73962784_73963855 | 3.39 |
D730045A05Rik |
RIKEN cDNA D730045A05 gene |
54588 |
0.13 |
chr9_52148115_52149635 | 3.36 |
Zc3h12c |
zinc finger CCCH type containing 12C |
19236 |
0.18 |
chr10_57784547_57786586 | 3.33 |
Fabp7 |
fatty acid binding protein 7, brain |
643 |
0.68 |
chr2_67565316_67565790 | 3.32 |
B3galt1 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 |
318 |
0.9 |
chr17_91093132_91093621 | 3.31 |
Nrxn1 |
neurexin I |
305 |
0.87 |
chrX_73914737_73915342 | 3.31 |
Arhgap4 |
Rho GTPase activating protein 4 |
3703 |
0.12 |
chr1_153345700_153346201 | 3.31 |
Lamc1 |
laminin, gamma 1 |
13164 |
0.16 |
chr8_119394554_119394878 | 3.31 |
Mlycd |
malonyl-CoA decarboxylase |
162 |
0.94 |
chr11_31169012_31169884 | 3.30 |
Gm17332 |
predicted gene, 17332 |
13014 |
0.19 |
chr5_120431744_120433119 | 3.30 |
Gm27199 |
predicted gene 27199 |
664 |
0.41 |
chr9_21196536_21198489 | 3.29 |
Pde4a |
phosphodiesterase 4A, cAMP specific |
807 |
0.45 |
chr10_34316245_34317506 | 3.29 |
Nt5dc1 |
5'-nucleotidase domain containing 1 |
3192 |
0.16 |
chr4_22485878_22486449 | 3.29 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
2203 |
0.26 |
chrX_36195589_36196935 | 3.29 |
Zcchc12 |
zinc finger, CCHC domain containing 12 |
276 |
0.9 |
chr5_134932138_134932360 | 3.28 |
Mettl27 |
methyltransferase like 27 |
119 |
0.86 |
chr17_33089287_33089514 | 3.28 |
Zfp563 |
zinc finger protein 563 |
90 |
0.96 |
chrX_143519847_143519998 | 3.28 |
Pak3 |
p21 (RAC1) activated kinase 3 |
1224 |
0.61 |
chr2_65622311_65622547 | 3.27 |
Scn2a |
sodium channel, voltage-gated, type II, alpha |
1618 |
0.46 |
chr11_121847461_121848143 | 3.27 |
Gm12586 |
predicted gene 12586 |
8971 |
0.13 |
chr15_99392866_99394083 | 3.27 |
Tmbim6 |
transmembrane BAX inhibitor motif containing 6 |
118 |
0.93 |
chr14_51113685_51113876 | 3.26 |
Eddm3b |
epididymal protein 3B |
646 |
0.48 |
chr2_158606104_158606672 | 3.25 |
Gm14204 |
predicted gene 14204 |
4202 |
0.13 |
chr6_55451730_55453138 | 3.24 |
Adcyap1r1 |
adenylate cyclase activating polypeptide 1 receptor 1 |
257 |
0.93 |
chr6_48536975_48537630 | 3.24 |
1700026J14Rik |
RIKEN cDNA 1700026J14 gene |
172 |
0.63 |
chr3_101379658_101381123 | 3.23 |
Igsf3 |
immunoglobulin superfamily, member 3 |
2052 |
0.26 |
chr7_78575992_78576673 | 3.23 |
Gm39038 |
predicted gene, 39038 |
1100 |
0.39 |
chr18_61737389_61738065 | 3.20 |
1500015A07Rik |
RIKEN cDNA 1500015A07 gene |
3370 |
0.17 |
chr7_78576803_78577063 | 3.20 |
Ntrk3 |
neurotrophic tyrosine kinase, receptor, type 3 |
850 |
0.49 |
chr3_34653590_34654523 | 3.18 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
1980 |
0.2 |
chr6_37592234_37592983 | 3.17 |
Gm7463 |
predicted gene 7463 |
51194 |
0.14 |
chr5_37248332_37249378 | 3.16 |
Crmp1 |
collapsin response mediator protein 1 |
1570 |
0.39 |
chr13_51566607_51568077 | 3.16 |
Shc3 |
src homology 2 domain-containing transforming protein C3 |
258 |
0.94 |
chr13_46217950_46218678 | 3.15 |
Gm10113 |
predicted gene 10113 |
27268 |
0.21 |
chr15_87626323_87626700 | 3.14 |
Tafa5 |
TAFA chemokine like family member 5 |
1281 |
0.63 |
chr17_56141491_56142567 | 3.14 |
Sema6b |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6B |
1686 |
0.19 |
chr7_119184137_119185474 | 3.12 |
Gpr139 |
G protein-coupled receptor 139 |
202 |
0.96 |
chrX_146962362_146963776 | 3.10 |
Htr2c |
5-hydroxytryptamine (serotonin) receptor 2C |
46 |
0.97 |
chr6_59023925_59024923 | 3.09 |
Fam13a |
family with sequence similarity 13, member A |
2 |
0.97 |
chr2_132578250_132578440 | 3.09 |
Gpcpd1 |
glycerophosphocholine phosphodiesterase 1 |
97 |
0.96 |
chr15_98180469_98181749 | 3.09 |
Ccdc184 |
coiled-coil domain containing 184 |
13951 |
0.1 |
chr11_3292563_3292885 | 3.06 |
Patz1 |
POZ (BTB) and AT hook containing zinc finger 1 |
144 |
0.93 |
chr15_89840162_89840372 | 3.04 |
Syt10 |
synaptotagmin X |
1593 |
0.45 |
chr4_109568983_109569401 | 3.04 |
Gm12811 |
predicted gene 12811 |
22 |
0.97 |
chr9_44043023_44044291 | 3.04 |
Thy1 |
thymus cell antigen 1, theta |
123 |
0.91 |
chr19_44266847_44267125 | 3.03 |
Gm35183 |
predicted gene, 35183 |
5285 |
0.12 |
chr3_84302497_84302941 | 3.03 |
Trim2 |
tripartite motif-containing 2 |
2022 |
0.41 |
chr6_70824007_70825186 | 3.03 |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
19919 |
0.13 |
chr6_119105806_119106254 | 3.03 |
Cacna1c |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
1945 |
0.44 |
chr2_32581182_32581681 | 3.02 |
Pip5kl1 |
phosphatidylinositol-4-phosphate 5-kinase-like 1 |
1504 |
0.19 |
chr7_45638519_45638961 | 3.02 |
A030001D20Rik |
RIKEN cDNA A030001D20 gene |
25 |
0.91 |
chr8_34890130_34891317 | 3.01 |
Tnks |
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase |
572 |
0.8 |
chr13_109118281_109118690 | 3.01 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
1844 |
0.52 |
chr2_65565600_65566271 | 3.00 |
Scn3a |
sodium channel, voltage-gated, type III, alpha |
1557 |
0.45 |
chr16_97165196_97166268 | 3.00 |
Dscam |
DS cell adhesion molecule |
5020 |
0.33 |
chr7_16959511_16960260 | 3.00 |
Pnmal1 |
PNMA-like 1 |
206 |
0.87 |
chr3_121967618_121967769 | 2.98 |
Arhgap29 |
Rho GTPase activating protein 29 |
136 |
0.96 |
chr8_55939901_55941088 | 2.97 |
Glra3 |
glycine receptor, alpha 3 subunit |
15 |
0.98 |
chr4_70530858_70531844 | 2.96 |
Megf9 |
multiple EGF-like-domains 9 |
3577 |
0.38 |
chr1_167600064_167600215 | 2.95 |
Rxrg |
retinoid X receptor gamma |
1659 |
0.48 |
chr15_100761227_100761777 | 2.95 |
Slc4a8 |
solute carrier family 4 (anion exchanger), member 8 |
245 |
0.89 |
chr17_34295833_34296830 | 2.94 |
H2-Aa |
histocompatibility 2, class II antigen A, alpha |
8508 |
0.08 |
chr7_44670379_44671440 | 2.93 |
Myh14 |
myosin, heavy polypeptide 14 |
66 |
0.94 |
chr2_122467029_122468235 | 2.92 |
Bambi-ps1 |
BMP and activin membrane-bound inhibitor, pseudogene (Xenopus laevis) |
106 |
0.96 |
chr9_91377840_91378089 | 2.92 |
Zic4 |
zinc finger protein of the cerebellum 4 |
233 |
0.88 |
chr13_109926306_109927455 | 2.90 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
36 |
0.98 |
chr11_34315414_34316667 | 2.90 |
Insyn2b |
inhibitory synaptic factor family member 2B |
1218 |
0.45 |
chr18_61707735_61708007 | 2.90 |
Pcyox1l |
prenylcysteine oxidase 1 like |
236 |
0.87 |
chr3_94478073_94479450 | 2.90 |
Celf3 |
CUGBP, Elav-like family member 3 |
70 |
0.92 |
chr4_109342938_109343450 | 2.88 |
Eps15 |
epidermal growth factor receptor pathway substrate 15 |
59 |
0.97 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 9.8 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
2.8 | 8.3 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
2.1 | 6.4 | GO:0021564 | vagus nerve development(GO:0021564) |
2.0 | 6.1 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
1.8 | 5.5 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
1.8 | 5.3 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
1.6 | 4.9 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
1.5 | 8.9 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.5 | 7.4 | GO:0070842 | aggresome assembly(GO:0070842) |
1.4 | 4.3 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
1.4 | 5.7 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
1.4 | 4.1 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
1.3 | 4.0 | GO:0045914 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
1.3 | 1.3 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
1.3 | 3.8 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
1.2 | 3.6 | GO:0021586 | pons maturation(GO:0021586) |
1.2 | 3.5 | GO:1902065 | response to L-glutamate(GO:1902065) |
1.1 | 3.4 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
1.1 | 1.1 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
1.1 | 5.5 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
1.1 | 1.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.0 | 10.4 | GO:0071625 | vocalization behavior(GO:0071625) |
1.0 | 6.0 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
1.0 | 7.0 | GO:0005513 | detection of calcium ion(GO:0005513) |
1.0 | 3.9 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
1.0 | 2.9 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
1.0 | 2.9 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
1.0 | 2.9 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
0.9 | 2.8 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.9 | 1.9 | GO:0043465 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
0.9 | 1.9 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.9 | 7.0 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.9 | 2.6 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.9 | 2.6 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.8 | 3.4 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.8 | 2.4 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.8 | 2.4 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.8 | 2.4 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.8 | 2.4 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.8 | 1.6 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.8 | 1.5 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.8 | 3.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.8 | 2.3 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.8 | 1.5 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.8 | 3.0 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.8 | 3.0 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.7 | 3.7 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.7 | 3.7 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.7 | 3.0 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.7 | 2.2 | GO:0030070 | insulin processing(GO:0030070) |
0.7 | 4.4 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.7 | 2.2 | GO:0015755 | fructose transport(GO:0015755) |
0.7 | 2.9 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.7 | 2.9 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.7 | 6.5 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.7 | 0.7 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.7 | 4.3 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.7 | 3.5 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.7 | 2.1 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.7 | 2.1 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.7 | 4.1 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.7 | 2.0 | GO:0046959 | habituation(GO:0046959) |
0.7 | 1.3 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.7 | 2.7 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.6 | 5.2 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.6 | 1.9 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.6 | 1.3 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.6 | 1.3 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.6 | 2.5 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.6 | 4.9 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.6 | 1.8 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.6 | 2.4 | GO:0001927 | exocyst assembly(GO:0001927) |
0.6 | 3.5 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.6 | 1.8 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.6 | 1.8 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.6 | 1.7 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.6 | 1.7 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.6 | 1.7 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.5 | 2.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.5 | 3.3 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.5 | 5.4 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.5 | 2.7 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.5 | 3.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.5 | 1.6 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.5 | 1.6 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.5 | 2.6 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.5 | 2.6 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.5 | 1.6 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.5 | 6.7 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.5 | 2.0 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.5 | 2.5 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
0.5 | 2.5 | GO:0090383 | phagosome acidification(GO:0090383) |
0.5 | 3.9 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.5 | 1.5 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.5 | 2.4 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.5 | 1.0 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.5 | 6.6 | GO:0001964 | startle response(GO:0001964) |
0.5 | 2.8 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.5 | 4.7 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.5 | 1.9 | GO:0006573 | valine metabolic process(GO:0006573) |
0.5 | 1.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.5 | 0.9 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.5 | 2.7 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.5 | 1.4 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.4 | 5.4 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.4 | 1.8 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.4 | 3.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.4 | 1.8 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.4 | 10.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.4 | 1.7 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.4 | 1.3 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.4 | 2.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.4 | 1.7 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.4 | 5.8 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.4 | 4.5 | GO:0036376 | sodium ion export from cell(GO:0036376) |
0.4 | 4.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.4 | 1.2 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.4 | 1.6 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.4 | 1.2 | GO:0006868 | glutamine transport(GO:0006868) |
0.4 | 0.4 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.4 | 1.2 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.4 | 1.2 | GO:0040031 | snRNA modification(GO:0040031) |
0.4 | 2.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.4 | 0.8 | GO:0072197 | ureter morphogenesis(GO:0072197) |
0.4 | 1.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.4 | 0.8 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.4 | 1.1 | GO:0060618 | nipple development(GO:0060618) |
0.4 | 0.8 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.4 | 1.1 | GO:0030242 | pexophagy(GO:0030242) |
0.4 | 6.9 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.4 | 1.9 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.4 | 3.0 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.4 | 1.9 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.4 | 1.1 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.4 | 2.2 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.4 | 1.1 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.4 | 0.7 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.4 | 0.4 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.4 | 2.1 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.4 | 1.4 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.4 | 1.1 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.4 | 1.4 | GO:0021636 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) |
0.4 | 2.8 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.4 | 1.8 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.4 | 3.2 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.3 | 1.0 | GO:0030035 | microspike assembly(GO:0030035) |
0.3 | 0.3 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.3 | 1.0 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.3 | 4.5 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.3 | 1.4 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.3 | 2.4 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.3 | 0.7 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.3 | 3.8 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.3 | 2.0 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.3 | 0.7 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.3 | 1.0 | GO:0090135 | actin filament branching(GO:0090135) |
0.3 | 3.7 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.3 | 2.0 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.3 | 1.7 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.3 | 0.7 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.3 | 3.0 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.3 | 0.7 | GO:0019086 | late viral transcription(GO:0019086) |
0.3 | 1.0 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.3 | 0.7 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.3 | 1.7 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.3 | 7.6 | GO:0006491 | N-glycan processing(GO:0006491) |
0.3 | 0.7 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.3 | 1.0 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.3 | 0.3 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.3 | 1.3 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.3 | 0.3 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.3 | 0.6 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.3 | 0.6 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
0.3 | 1.3 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) |
0.3 | 0.6 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.3 | 0.9 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.3 | 0.9 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.3 | 1.2 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.3 | 0.6 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.3 | 1.2 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.3 | 1.5 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.3 | 1.2 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.3 | 1.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 0.6 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.3 | 0.6 | GO:0007412 | axon target recognition(GO:0007412) |
0.3 | 1.5 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.3 | 2.4 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.3 | 0.9 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.3 | 0.6 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.3 | 0.9 | GO:0060179 | male mating behavior(GO:0060179) |
0.3 | 1.5 | GO:0034776 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
0.3 | 3.5 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.3 | 0.9 | GO:0015819 | lysine transport(GO:0015819) |
0.3 | 0.9 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.3 | 1.1 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 4.8 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.3 | 0.8 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.3 | 1.7 | GO:0097264 | self proteolysis(GO:0097264) |
0.3 | 1.1 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.3 | 2.2 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.3 | 0.8 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.3 | 0.8 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.3 | 0.3 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.3 | 1.7 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.3 | 1.1 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.3 | 0.8 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.3 | 2.2 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.3 | 0.5 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.3 | 1.9 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.3 | 0.5 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.3 | 0.5 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.3 | 1.1 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.3 | 0.5 | GO:0023058 | adaptation of signaling pathway(GO:0023058) |
0.3 | 1.3 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.3 | 0.5 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.3 | 0.8 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.3 | 0.5 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.3 | 1.8 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.3 | 0.8 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.3 | 0.8 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.3 | 1.6 | GO:0016322 | neuron remodeling(GO:0016322) |
0.3 | 1.8 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.3 | 2.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.3 | 14.1 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.3 | 1.0 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.3 | 0.8 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.3 | 1.0 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.3 | 2.0 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.3 | 0.8 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.3 | 1.3 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.2 | 0.7 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.2 | 2.5 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.2 | 3.4 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.7 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.2 | 0.7 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.2 | 0.2 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.2 | 1.0 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.2 | 1.0 | GO:0042891 | antibiotic transport(GO:0042891) |
0.2 | 4.1 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.2 | 0.7 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.2 | 0.5 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.2 | 0.2 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.2 | 2.6 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.2 | 0.5 | GO:0098598 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
0.2 | 8.1 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.2 | 21.1 | GO:0007612 | learning(GO:0007612) |
0.2 | 0.5 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.2 | 1.2 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.2 | 0.7 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.2 | 0.2 | GO:0043133 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.2 | 0.9 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.2 | 1.4 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.2 | 0.2 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.2 | 0.2 | GO:2000978 | negative regulation of forebrain neuron differentiation(GO:2000978) |
0.2 | 1.6 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.2 | 0.7 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.2 | 0.4 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 0.4 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.2 | 0.4 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.2 | 0.2 | GO:0042762 | regulation of sulfur metabolic process(GO:0042762) |
0.2 | 0.6 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
0.2 | 4.3 | GO:0032094 | response to food(GO:0032094) |
0.2 | 0.2 | GO:0017085 | response to insecticide(GO:0017085) |
0.2 | 0.6 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.2 | 0.9 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.2 | 1.7 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 2.1 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.2 | 0.2 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.2 | 0.6 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.2 | 0.8 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.2 | 0.4 | GO:1903596 | regulation of gap junction assembly(GO:1903596) |
0.2 | 0.6 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.2 | 3.3 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.2 | 0.2 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.2 | 0.6 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 5.6 | GO:0021766 | hippocampus development(GO:0021766) |
0.2 | 0.6 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
0.2 | 0.2 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.2 | 0.2 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.2 | 1.0 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.2 | 0.6 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.2 | 0.6 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.2 | 1.0 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.2 | 1.6 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.2 | 0.4 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.2 | 0.6 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.2 | 1.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.2 | 0.6 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.2 | 0.6 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.2 | 1.2 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.2 | 0.4 | GO:0060174 | limb bud formation(GO:0060174) |
0.2 | 1.2 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.2 | 0.2 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.2 | 0.6 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.2 | 0.8 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.2 | 0.6 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.2 | 0.9 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.2 | 1.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.2 | 0.2 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.2 | 2.8 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.2 | 0.7 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 0.6 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.2 | 0.7 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.2 | 0.5 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.2 | 0.4 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.2 | 1.1 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.2 | 0.5 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.2 | 0.9 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.2 | 0.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 0.4 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.2 | 0.4 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.2 | 1.8 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.2 | 0.4 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.2 | 0.4 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.2 | 0.4 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.2 | 0.4 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.2 | 0.5 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.2 | 0.3 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.2 | 2.4 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.2 | 0.7 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.2 | 0.5 | GO:0009414 | response to water deprivation(GO:0009414) |
0.2 | 1.0 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.2 | 0.3 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 0.5 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.2 | 1.4 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.2 | 0.2 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.2 | 0.2 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.2 | 1.2 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.2 | 1.3 | GO:0033572 | transferrin transport(GO:0033572) |
0.2 | 0.5 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.2 | 0.3 | GO:0051593 | response to folic acid(GO:0051593) |
0.2 | 0.7 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.2 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.2 | 0.3 | GO:0010288 | response to lead ion(GO:0010288) |
0.2 | 0.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 0.8 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.2 | 0.7 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.2 | 0.5 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.2 | 0.5 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.2 | 0.2 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.2 | 0.3 | GO:0060166 | olfactory pit development(GO:0060166) |
0.2 | 0.2 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.2 | 0.7 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.2 | 3.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.2 | 0.6 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.2 | 0.5 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.2 | 0.8 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.2 | 0.5 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.2 | 0.5 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.2 | 0.3 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.2 | 0.5 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.2 | 0.8 | GO:0015871 | choline transport(GO:0015871) |
0.2 | 1.1 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.2 | 0.8 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.2 | 0.2 | GO:0002339 | B cell selection(GO:0002339) |
0.2 | 2.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.2 | 0.3 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.2 | 0.9 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.2 | 0.2 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.2 | 1.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.2 | 7.3 | GO:0021549 | cerebellum development(GO:0021549) |
0.2 | 0.3 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.2 | 0.9 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 1.1 | GO:0035640 | exploration behavior(GO:0035640) |
0.2 | 3.7 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.2 | 0.9 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.2 | 0.6 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.2 | 0.6 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.2 | 0.3 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.2 | 0.5 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.2 | 0.6 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.1 | 1.0 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.1 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.1 | 0.4 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.1 | 0.3 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.9 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.3 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.1 | 0.3 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.7 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 1.0 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 0.3 | GO:0097503 | sialylation(GO:0097503) |
0.1 | 0.4 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 0.6 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.4 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 1.4 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.6 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.3 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 4.0 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 0.3 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.1 | 0.3 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.7 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.8 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.1 | 0.7 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.1 | 0.3 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 0.7 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 0.1 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.1 | 1.0 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.1 | 0.6 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.1 | 0.6 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 2.9 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 2.5 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.1 | 2.9 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 0.1 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
0.1 | 0.1 | GO:0086068 | Purkinje myocyte action potential(GO:0086017) Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.1 | 0.8 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 0.4 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.4 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.1 | 2.3 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 0.4 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 0.1 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.1 | 0.5 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.7 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.1 | 2.2 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.4 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 0.3 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.1 | 0.1 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 0.4 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.6 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 1.8 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.3 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.1 | 1.0 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.1 | 0.9 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 1.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 3.0 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.8 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.1 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 1.4 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 0.4 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.2 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.1 | 0.4 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.9 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.1 | 0.1 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.1 | 0.1 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.1 | 1.6 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 0.4 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 0.1 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.1 | 1.5 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 1.6 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 0.2 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.2 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.1 | 0.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.4 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.2 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.1 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.1 | 0.4 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 0.7 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.2 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 1.4 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 0.6 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.8 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.6 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 0.5 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 1.1 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.3 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.1 | 0.2 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.1 | 0.3 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.5 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.1 | 0.4 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.1 | 3.4 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.1 | 0.2 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 1.2 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.9 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 5.1 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.1 | 1.0 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 3.6 | GO:0007269 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.1 | 0.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 2.0 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.8 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 1.5 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 0.4 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.1 | 0.5 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 | 0.2 | GO:0035933 | glucocorticoid secretion(GO:0035933) regulation of glucocorticoid secretion(GO:2000849) |
0.1 | 0.1 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 8.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.3 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.1 | 0.1 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.1 | 0.3 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.1 | 0.1 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 0.2 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.1 | 0.4 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.1 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.1 | 1.6 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 0.6 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.1 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.1 | 2.2 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 1.5 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.2 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.4 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.6 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.3 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.1 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 0.5 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.1 | 1.4 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.1 | 0.7 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.4 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.2 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.1 | 0.9 | GO:0002209 | behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) |
0.1 | 0.7 | GO:0060074 | synapse maturation(GO:0060074) |
0.1 | 0.1 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.1 | 1.0 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 1.2 | GO:0071242 | cellular response to ammonium ion(GO:0071242) |
0.1 | 0.1 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.1 | 0.2 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.1 | 0.7 | GO:0030220 | platelet formation(GO:0030220) |
0.1 | 0.4 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 7.0 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.1 | 0.6 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.1 | GO:0019243 | methylglyoxal metabolic process(GO:0009438) methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.1 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.1 | 0.8 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.2 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 0.2 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.1 | 0.3 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.1 | GO:0090467 | regulation of L-arginine import(GO:0010963) L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.1 | 0.3 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.1 | 0.2 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 0.4 | GO:0071435 | potassium ion export(GO:0071435) |
0.1 | 2.7 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.1 | 0.2 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.1 | 0.1 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.1 | 0.4 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.2 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.1 | 0.6 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.1 | 0.2 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.1 | 0.4 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 0.7 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.1 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.1 | 0.3 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.1 | 0.4 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.1 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.1 | 0.6 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 1.1 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 1.4 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.1 | 0.1 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 0.3 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 0.5 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.6 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.1 | 0.4 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.2 | GO:1902075 | cellular response to salt(GO:1902075) |
0.1 | 0.2 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.1 | 0.9 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.5 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.3 | GO:2000510 | regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.1 | 0.4 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 0.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.5 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.6 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.2 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.1 | 0.2 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.1 | 3.7 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 0.2 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 3.7 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.1 | GO:0071888 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.1 | 0.3 | GO:0035646 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.1 | 0.3 | GO:1903624 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
0.1 | 0.6 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.1 | 0.3 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.1 | 0.4 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.1 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.1 | 0.2 | GO:0032762 | mast cell cytokine production(GO:0032762) |
0.1 | 0.2 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.1 | 0.1 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 3.6 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 0.1 | GO:0032375 | negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) |
0.1 | 0.2 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 0.4 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.1 | 1.1 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.1 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.9 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.2 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.2 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.2 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.1 | 1.3 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.1 | 0.4 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 0.3 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.3 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.2 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.1 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.1 | 0.3 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 0.4 | GO:0060004 | reflex(GO:0060004) |
0.1 | 0.3 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.1 | 0.1 | GO:0009642 | response to light intensity(GO:0009642) |
0.1 | 0.4 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.5 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.1 | GO:0090148 | membrane fission(GO:0090148) |
0.1 | 2.3 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.9 | GO:0044088 | regulation of vacuole organization(GO:0044088) |
0.1 | 0.2 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 0.3 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.4 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.1 | 0.1 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 0.2 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 0.6 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 0.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.1 | GO:0046066 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.1 | 0.3 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 0.8 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 0.1 | GO:0033121 | regulation of purine nucleotide catabolic process(GO:0033121) |
0.1 | 0.1 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.1 | 0.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.1 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.1 | 0.6 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 0.3 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.2 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.1 | 0.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.1 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.1 | 0.1 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 0.4 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.1 | 1.2 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.1 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.1 | 0.1 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.1 | 0.1 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.1 | 1.2 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.1 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.1 | 0.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.5 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.1 | 0.4 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 0.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.3 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 0.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.2 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 1.0 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.1 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.1 | 0.2 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.1 | 0.1 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.1 | 0.4 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 0.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.2 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.1 | 0.2 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.1 | 0.1 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.1 | 0.5 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.1 | 0.7 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.1 | 0.2 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 1.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.2 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 1.6 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 0.2 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.1 | 0.5 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.1 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.1 | 0.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.1 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.1 | 0.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.8 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.3 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.3 | GO:0046051 | UTP metabolic process(GO:0046051) |
0.1 | 0.6 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 0.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.4 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.1 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.1 | 0.2 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.1 | 0.1 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.1 | 1.3 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.1 | 0.8 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.1 | 2.2 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.3 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.1 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.1 | 0.1 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.1 | 1.9 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 0.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 0.1 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.1 | 0.1 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
0.1 | 0.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.1 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
0.1 | 0.1 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.1 | 0.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.2 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.1 | 0.2 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.1 | 0.2 | GO:0010560 | positive regulation of glycoprotein biosynthetic process(GO:0010560) |
0.1 | 0.3 | GO:0001510 | RNA methylation(GO:0001510) |
0.1 | 0.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.1 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.1 | 0.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 0.4 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.1 | 0.1 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.1 | 0.2 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.1 | 0.2 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.1 | 0.3 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.1 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.2 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 0.7 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.1 | 0.7 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 1.2 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.0 | 0.2 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.0 | 0.2 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.0 | 0.1 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.1 | GO:0001810 | regulation of type I hypersensitivity(GO:0001810) positive regulation of type I hypersensitivity(GO:0001812) type I hypersensitivity(GO:0016068) |
0.0 | 0.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 0.4 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.4 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.1 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.0 | 0.1 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.0 | 0.2 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.0 | 0.1 | GO:0009415 | response to water(GO:0009415) |
0.0 | 0.2 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.0 | 0.2 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.0 | 0.0 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.0 | 0.3 | GO:0048679 | regulation of axon regeneration(GO:0048679) |
0.0 | 0.0 | GO:0015744 | succinate transport(GO:0015744) |
0.0 | 2.3 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.0 | 0.3 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.0 | 0.0 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.0 | 0.0 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.0 | 0.1 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.0 | 0.0 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.0 | 0.1 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.0 | 0.0 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.2 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 1.5 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.6 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.1 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
0.0 | 0.0 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.0 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.2 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.0 | 0.2 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.1 | GO:0097479 | synaptic vesicle localization(GO:0097479) |
0.0 | 0.3 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.0 | 0.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.0 | 0.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) regulation of sodium-dependent phosphate transport(GO:2000118) |
0.0 | 0.0 | GO:0051589 | negative regulation of neurotransmitter transport(GO:0051589) |
0.0 | 0.1 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.0 | 0.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 0.2 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.0 | 0.1 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.0 | 0.1 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 0.1 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.0 | 0.2 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
0.0 | 0.1 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.0 | 0.2 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.0 | 0.2 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.0 | 0.4 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.1 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.0 | 0.1 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.0 | 0.4 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.2 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.0 | 0.1 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.0 | 0.2 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.0 | 0.3 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.1 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.0 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.0 | 0.0 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.0 | 0.0 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.0 | 0.3 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.0 | 0.1 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.0 | 0.8 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.0 | 0.2 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.0 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.2 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.0 | GO:0072350 | tricarboxylic acid metabolic process(GO:0072350) |
0.0 | 0.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.0 | 0.6 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.0 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.0 | 0.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.2 | GO:0031112 | positive regulation of microtubule polymerization or depolymerization(GO:0031112) |
0.0 | 0.1 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.0 | 0.1 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.0 | 0.1 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.0 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.1 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.0 | 0.0 | GO:0002434 | immune complex clearance(GO:0002434) |
0.0 | 0.2 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.0 | 0.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.0 | 0.5 | GO:0031641 | regulation of myelination(GO:0031641) |
0.0 | 0.1 | GO:1904754 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.0 | 0.3 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.0 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) |
0.0 | 0.3 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.3 | GO:0009620 | response to fungus(GO:0009620) |
0.0 | 0.1 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 0.1 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.3 | GO:0007099 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.0 | 0.0 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.0 | 0.1 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.0 | 0.1 | GO:0045876 | regulation of maintenance of sister chromatid cohesion(GO:0034091) positive regulation of maintenance of sister chromatid cohesion(GO:0034093) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) positive regulation of sister chromatid cohesion(GO:0045876) |
0.0 | 0.4 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.0 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.0 | 0.0 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.0 | 0.0 | GO:0097049 | motor neuron apoptotic process(GO:0097049) |
0.0 | 0.0 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.0 | 0.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.0 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.0 | 0.1 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.0 | 0.1 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.0 | 0.2 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.0 | 0.2 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.0 | 0.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.1 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.0 | 0.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.0 | 0.6 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.1 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.2 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.3 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
0.0 | 0.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.1 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.2 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.1 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.0 | 0.1 | GO:0009838 | abscission(GO:0009838) |
0.0 | 0.0 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.0 | 1.0 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.1 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 0.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.1 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.0 | 0.4 | GO:0009268 | response to pH(GO:0009268) |
0.0 | 0.0 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.0 | 0.4 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.0 | 0.5 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.0 | 0.1 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.0 | 0.0 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.0 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.0 | 0.0 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.0 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.1 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
0.0 | 0.1 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.0 | 0.0 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.0 | 0.0 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.0 | 0.1 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.0 | 0.0 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.0 | 0.0 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.0 | 0.2 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.1 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.0 | 0.4 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.0 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.0 | 0.1 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.0 | 0.0 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.0 | 0.1 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.0 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.0 | 0.0 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.0 | 0.2 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.0 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.0 | 0.1 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.0 | GO:0002254 | kinin cascade(GO:0002254) |
0.0 | 0.1 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.0 | 0.0 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.0 | 0.0 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.0 | 0.0 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.1 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.0 | 0.1 | GO:0042348 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.0 | 0.0 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.0 | 0.1 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.0 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.0 | 0.1 | GO:0006400 | tRNA modification(GO:0006400) |
0.0 | 0.1 | GO:0002481 | antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
0.0 | 0.0 | GO:0018377 | protein myristoylation(GO:0018377) |
0.0 | 0.0 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.0 | 0.1 | GO:0015825 | L-serine transport(GO:0015825) |
0.0 | 0.1 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.0 | 0.0 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.0 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.0 | 0.1 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.0 | 0.0 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.0 | 0.0 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.0 | 0.0 | GO:0071675 | regulation of mononuclear cell migration(GO:0071675) |
0.0 | 0.1 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.0 | 0.1 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 0.2 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.0 | 0.0 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.0 | 0.0 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.0 | 0.0 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.0 | 0.1 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.0 | 0.0 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.2 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.1 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.0 | 0.0 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.0 | 0.0 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.1 | GO:0042220 | response to cocaine(GO:0042220) |
0.0 | 0.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.0 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.0 | 0.0 | GO:0070316 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) negative regulation of G0 to G1 transition(GO:0070317) |
0.0 | 0.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.0 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.0 | 0.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 0.2 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 0.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.0 | 0.0 | GO:0010934 | macrophage cytokine production(GO:0010934) regulation of macrophage cytokine production(GO:0010935) myeloid leukocyte cytokine production(GO:0061082) |
0.0 | 0.0 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.0 | 0.0 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.0 | 0.0 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.0 | 0.1 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.0 | 0.0 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.0 | 0.1 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.0 | 0.0 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.0 | 0.4 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.0 | 0.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.0 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.0 | 0.0 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.0 | 0.0 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.0 | 0.1 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.0 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.0 | 0.0 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.0 | 0.2 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.0 | 0.0 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.0 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.0 | 0.0 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.0 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.0 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.0 | 0.0 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.0 | 0.0 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.0 | 0.0 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.0 | 0.0 | GO:1990144 | intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.0 | 0.0 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.0 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 0.2 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.0 | 0.0 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.0 | 0.1 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.0 | 0.0 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.0 | 0.0 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 7.4 | GO:0044308 | axonal spine(GO:0044308) |
1.3 | 3.9 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.1 | 8.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.1 | 4.3 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
1.0 | 2.9 | GO:0097513 | myosin II filament(GO:0097513) |
0.9 | 8.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.9 | 2.8 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.9 | 5.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.9 | 3.4 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.8 | 11.7 | GO:0071565 | nBAF complex(GO:0071565) |
0.8 | 6.4 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.7 | 2.2 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.7 | 2.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.7 | 2.9 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.7 | 0.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.7 | 2.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.7 | 2.7 | GO:0033269 | internode region of axon(GO:0033269) |
0.6 | 3.2 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.6 | 5.0 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.6 | 6.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.6 | 2.9 | GO:0070820 | tertiary granule(GO:0070820) |
0.6 | 1.2 | GO:0044393 | microspike(GO:0044393) |
0.6 | 10.4 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.5 | 1.6 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.5 | 8.1 | GO:0031045 | dense core granule(GO:0031045) |
0.5 | 1.6 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.5 | 1.1 | GO:1990635 | proximal dendrite(GO:1990635) |
0.5 | 2.1 | GO:0044327 | dendritic spine head(GO:0044327) |
0.5 | 15.8 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.5 | 13.9 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.5 | 4.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.4 | 7.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.4 | 4.8 | GO:0035102 | PRC1 complex(GO:0035102) |
0.4 | 21.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.4 | 2.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.4 | 1.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.4 | 2.5 | GO:0043083 | synaptic cleft(GO:0043083) |
0.4 | 1.2 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.4 | 1.9 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.4 | 3.8 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.4 | 4.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.4 | 1.9 | GO:0070695 | FHF complex(GO:0070695) |
0.4 | 2.2 | GO:0097449 | astrocyte projection(GO:0097449) |
0.4 | 1.8 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.3 | 2.8 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.3 | 1.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.3 | 1.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.3 | 2.4 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.3 | 2.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 1.3 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.3 | 0.9 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.3 | 1.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.3 | 2.4 | GO:0005883 | neurofilament(GO:0005883) |
0.3 | 0.9 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.3 | 0.9 | GO:0043293 | apoptosome(GO:0043293) |
0.3 | 0.9 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.3 | 0.6 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.3 | 1.9 | GO:0032584 | growth cone membrane(GO:0032584) |
0.3 | 0.5 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.3 | 0.8 | GO:0000802 | transverse filament(GO:0000802) |
0.3 | 0.5 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.3 | 1.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.3 | 0.3 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.2 | 8.7 | GO:0043198 | dendritic shaft(GO:0043198) |
0.2 | 0.7 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.2 | 1.2 | GO:0097433 | dense body(GO:0097433) |
0.2 | 1.0 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 5.4 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.2 | 0.2 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.2 | 2.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.2 | 0.9 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.2 | 1.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 2.0 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 0.6 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 0.6 | GO:0031417 | NatC complex(GO:0031417) |
0.2 | 2.7 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.2 | 3.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 3.9 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 1.6 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 3.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 1.5 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.2 | 0.6 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 26.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 0.7 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.2 | 1.7 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 0.9 | GO:0033503 | HULC complex(GO:0033503) |
0.2 | 9.4 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.2 | 2.0 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 1.9 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.2 | 0.9 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.2 | 0.5 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 1.4 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 2.8 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 1.0 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 3.5 | GO:0097060 | synaptic membrane(GO:0097060) |
0.2 | 1.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 9.8 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 1.8 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.2 | 0.5 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.2 | 1.9 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 0.9 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.2 | 1.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 2.0 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 18.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.3 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 1.0 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 6.0 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.1 | 8.8 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.9 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 1.4 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 0.9 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 1.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 40.5 | GO:0030425 | dendrite(GO:0030425) |
0.1 | 0.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 6.7 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 0.8 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 1.4 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 0.5 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.4 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 0.6 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.2 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 0.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 0.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.8 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 1.8 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.7 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.1 | 0.6 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.3 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.5 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.1 | 1.5 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 0.3 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.6 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.1 | 1.1 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.1 | 0.9 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.8 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.6 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 0.3 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.1 | 0.5 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.5 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 2.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.7 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.4 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 1.4 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 0.1 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 1.2 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 1.2 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 0.3 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 0.5 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 6.8 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 4.4 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.1 | 0.3 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 0.4 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.6 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 0.3 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.1 | 0.5 | GO:0001939 | female pronucleus(GO:0001939) |
0.1 | 0.8 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.7 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.6 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.2 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 2.0 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 7.9 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 0.8 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 3.7 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 0.3 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 2.9 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 3.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 0.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 2.3 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 1.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 3.5 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 0.4 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 2.1 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.1 | 0.4 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 2.5 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.1 | 2.1 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 4.0 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 1.0 | GO:0072372 | primary cilium(GO:0072372) |
0.1 | 0.3 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 7.5 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.1 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 0.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.3 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 0.1 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 0.6 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 1.1 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 3.3 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.8 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 2.6 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 2.1 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 2.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 3.5 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 0.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.1 | GO:0030662 | coated vesicle membrane(GO:0030662) |
0.1 | 0.2 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.1 | 0.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 1.1 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 3.8 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.1 | 0.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 0.1 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 1.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.3 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.2 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 0.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.1 | 0.8 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.1 | 0.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.5 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.4 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.6 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.0 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 1.1 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 0.1 | GO:0000805 | X chromosome(GO:0000805) |
0.0 | 0.0 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.6 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 3.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.7 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.8 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.6 | GO:0030659 | cytoplasmic vesicle membrane(GO:0030659) |
0.0 | 0.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.0 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.0 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.0 | 0.2 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.9 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.2 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.7 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.0 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.0 | 0.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.2 | GO:0043679 | axon terminus(GO:0043679) |
0.0 | 2.1 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.2 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.0 | 0.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.2 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.0 | 0.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.1 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 1.1 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.3 | GO:0031011 | Ino80 complex(GO:0031011) |
0.0 | 0.2 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.3 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 3.4 | GO:0016604 | nuclear body(GO:0016604) |
0.0 | 0.6 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 1.6 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.3 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 0.6 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.6 | GO:0016234 | inclusion body(GO:0016234) |
0.0 | 0.3 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.0 | 0.8 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.0 | 33.2 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.2 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.0 | 0.1 | GO:0044437 | vacuolar part(GO:0044437) |
0.0 | 0.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.0 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 0.1 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.0 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.2 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.8 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 0.1 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.1 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.1 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 2.0 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 0.0 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.0 | 0.1 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.1 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.0 | 0.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 3.4 | GO:0005773 | vacuole(GO:0005773) |
0.0 | 0.0 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 0.0 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.0 | GO:0005712 | chiasma(GO:0005712) |
0.0 | 0.2 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.1 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.1 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 0.0 | GO:0097413 | Lewy body(GO:0097413) |
0.0 | 0.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.0 | 0.0 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 54.8 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
0.0 | 0.0 | GO:0030689 | Noc complex(GO:0030689) |
0.0 | 0.0 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.2 | GO:0000502 | proteasome complex(GO:0000502) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.0 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
1.5 | 4.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.4 | 4.1 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.2 | 4.8 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.1 | 2.3 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
1.1 | 3.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.0 | 3.1 | GO:2001070 | starch binding(GO:2001070) |
1.0 | 3.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.0 | 3.0 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.0 | 1.9 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.9 | 2.6 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.9 | 11.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.9 | 3.5 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.9 | 4.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.8 | 4.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.8 | 3.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.8 | 3.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.8 | 4.0 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.8 | 4.0 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.8 | 2.4 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.8 | 4.7 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.8 | 2.3 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.8 | 3.0 | GO:0050693 | LBD domain binding(GO:0050693) |
0.8 | 2.3 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.7 | 3.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.7 | 2.9 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.7 | 4.9 | GO:0003680 | AT DNA binding(GO:0003680) |
0.7 | 2.8 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.7 | 2.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.7 | 2.8 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.7 | 6.8 | GO:0051378 | serotonin binding(GO:0051378) |
0.7 | 1.3 | GO:0048030 | disaccharide binding(GO:0048030) |
0.7 | 6.0 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.7 | 2.6 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.6 | 2.5 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.6 | 1.9 | GO:0005119 | smoothened binding(GO:0005119) |
0.6 | 3.4 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.6 | 3.9 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.6 | 1.7 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.6 | 1.7 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.5 | 1.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.5 | 2.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.5 | 2.7 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.5 | 2.2 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.5 | 1.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.5 | 6.7 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.5 | 2.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.5 | 2.0 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.5 | 1.0 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.5 | 11.1 | GO:0044688 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.5 | 2.5 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.5 | 3.5 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.5 | 2.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.5 | 1.9 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.5 | 1.4 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.5 | 3.8 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.5 | 2.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.5 | 1.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.5 | 4.1 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.4 | 2.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.4 | 3.6 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.4 | 2.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.4 | 5.3 | GO:0031005 | filamin binding(GO:0031005) |
0.4 | 0.4 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.4 | 1.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.4 | 8.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.4 | 1.3 | GO:0035939 | microsatellite binding(GO:0035939) |
0.4 | 1.3 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.4 | 1.3 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.4 | 4.6 | GO:0005522 | profilin binding(GO:0005522) |
0.4 | 2.5 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.4 | 0.4 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.4 | 2.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.4 | 1.6 | GO:0097001 | ceramide binding(GO:0097001) |
0.4 | 1.2 | GO:0018573 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.4 | 2.5 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.4 | 2.0 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.4 | 0.8 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.4 | 9.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.4 | 2.7 | GO:0033691 | sialic acid binding(GO:0033691) |
0.4 | 3.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.4 | 1.5 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.4 | 3.4 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.4 | 2.3 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.4 | 2.6 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.4 | 1.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.4 | 1.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.4 | 1.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.4 | 0.4 | GO:0016015 | morphogen activity(GO:0016015) |
0.4 | 1.1 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.4 | 2.5 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.4 | 1.8 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.4 | 0.4 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.4 | 1.8 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.4 | 2.8 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.3 | 1.0 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.3 | 1.0 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.3 | 1.4 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.3 | 2.0 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.3 | 1.0 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.3 | 5.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.3 | 1.0 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.3 | 2.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.3 | 1.0 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.3 | 4.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.3 | 1.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.3 | 2.8 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.3 | 1.2 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.3 | 0.3 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.3 | 1.5 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.3 | 0.9 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.3 | 0.9 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.3 | 0.9 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.3 | 1.2 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.3 | 1.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.3 | 5.4 | GO:0005112 | Notch binding(GO:0005112) |
0.3 | 0.3 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.3 | 2.9 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.3 | 9.1 | GO:0043883 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.3 | 0.8 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.3 | 5.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.3 | 0.8 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.3 | 0.3 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.3 | 0.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.3 | 1.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.3 | 0.5 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.3 | 1.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.3 | 4.5 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.3 | 3.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.3 | 1.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.3 | 0.5 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.3 | 1.0 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.3 | 0.3 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.3 | 6.7 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.3 | 2.8 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.3 | 0.3 | GO:0038191 | neuropilin binding(GO:0038191) |
0.3 | 2.8 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 2.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 1.0 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.2 | 2.7 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 1.2 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.2 | 0.7 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.2 | 0.7 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.2 | 1.2 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.2 | 0.5 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.2 | 1.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.2 | 0.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.2 | 0.9 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 1.6 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.2 | 0.5 | GO:0070905 | serine binding(GO:0070905) |
0.2 | 0.4 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 3.5 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.2 | 4.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 1.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 1.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 1.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 0.6 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 0.6 | GO:0070061 | fructose binding(GO:0070061) |
0.2 | 2.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 0.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.2 | 3.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 1.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 2.1 | GO:0016595 | glutamate binding(GO:0016595) |
0.2 | 7.2 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.2 | 2.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 3.3 | GO:0044654 | dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
0.2 | 4.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 1.8 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 3.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 1.0 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 0.2 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.2 | 3.6 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.2 | 0.6 | GO:0004096 | catalase activity(GO:0004096) |
0.2 | 0.6 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.2 | 3.1 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.2 | 0.6 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.2 | 0.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 0.8 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.2 | 0.9 | GO:0034785 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.2 | 4.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 0.2 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.2 | 0.4 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.2 | 1.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.2 | 0.6 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.2 | 3.9 | GO:0052828 | phosphohistidine phosphatase activity(GO:0008969) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) NADP phosphatase activity(GO:0019178) 5-amino-6-(5-phosphoribitylamino)uracil phosphatase activity(GO:0043726) phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) phosphatidylinositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052867) IDP phosphatase activity(GO:1990003) |
0.2 | 0.2 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
0.2 | 0.4 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.2 | 0.7 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 0.9 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.2 | 1.1 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.2 | 2.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 0.4 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.2 | 0.4 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.2 | 4.2 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.2 | 3.7 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.2 | 0.9 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 2.8 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.2 | 0.5 | GO:0005272 | sodium channel activity(GO:0005272) |
0.2 | 1.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 2.4 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.2 | 0.8 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 2.1 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 0.8 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 0.3 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.2 | 0.5 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.2 | 0.8 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.2 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 0.8 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 0.5 | GO:0004103 | choline kinase activity(GO:0004103) |
0.2 | 1.7 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.2 | 1.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 0.5 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 2.1 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.2 | 14.8 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.2 | 0.5 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.2 | 0.3 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.1 | 0.3 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.1 | 1.5 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 0.7 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.7 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 0.1 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.1 | 0.3 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 2.0 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 7.7 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 0.7 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.1 | 0.3 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.3 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 2.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.4 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.5 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.8 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.4 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 1.9 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 1.5 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 0.4 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.3 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 4.1 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 1.7 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.9 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 1.8 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 0.5 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.5 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 1.3 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.5 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.4 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 1.9 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 0.1 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.1 | 1.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.6 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 2.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.2 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.6 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 0.1 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 1.4 | GO:0015149 | hexose transmembrane transporter activity(GO:0015149) |
0.1 | 0.5 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.1 | 0.3 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.1 | 0.3 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.1 | 0.6 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 3.4 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.1 | 0.4 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.5 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 1.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.2 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.5 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 2.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 1.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 1.0 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.3 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 0.1 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.1 | 0.4 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 0.3 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 1.3 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.5 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 0.3 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.7 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 2.0 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.6 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.3 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 0.6 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.1 | 0.4 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 0.3 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.1 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.1 | 1.7 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 0.5 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.5 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 2.1 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.1 | 0.1 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.8 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 0.2 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.1 | 2.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 2.7 | GO:0005267 | potassium channel activity(GO:0005267) |
0.1 | 0.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 1.2 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.1 | 0.3 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 2.9 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 0.3 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 1.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.8 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.4 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.3 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 0.7 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.4 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 1.3 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 0.3 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 0.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.3 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.5 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.1 | 0.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.6 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 1.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.2 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 0.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 1.9 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 1.2 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 2.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.2 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 0.2 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.6 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.8 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 1.2 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 1.2 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.7 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 5.0 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 1.8 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 7.1 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.1 | 0.3 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.2 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 0.8 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 10.6 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 1.5 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 2.8 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 1.4 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.1 | 0.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 0.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 1.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.4 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 3.8 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 0.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.9 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.1 | 0.4 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.1 | 0.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.2 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.9 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 2.1 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.1 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.1 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.6 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 0.3 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 0.3 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 2.7 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.1 | 0.1 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.1 | GO:0032564 | dATP binding(GO:0032564) |
0.1 | 1.3 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 6.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.2 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 0.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.5 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.1 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 1.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 1.0 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.1 | 0.7 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 0.2 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.1 | 0.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.3 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 3.7 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 0.1 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
0.1 | 0.3 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 4.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 0.2 | GO:0015172 | acidic amino acid transmembrane transporter activity(GO:0015172) |
0.1 | 0.2 | GO:0008932 | lytic endotransglycosylase activity(GO:0008932) |
0.1 | 0.1 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.1 | 0.5 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 1.3 | GO:0045543 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.1 | 0.2 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 2.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.6 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.3 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.6 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.5 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.7 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 1.2 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 1.5 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.4 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.1 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.0 | 2.4 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.2 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.2 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.0 | 1.6 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.0 | 2.7 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.0 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.0 | 1.0 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.6 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.0 | 0.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.6 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.4 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.0 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.3 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.0 | 0.0 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 0.4 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.4 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.6 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.0 | GO:0016436 | rRNA methyltransferase activity(GO:0008649) rRNA (uridine) methyltransferase activity(GO:0016436) |
0.0 | 0.2 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 1.5 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 3.2 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 0.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 0.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 0.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.1 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.0 | 0.0 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.0 | 0.2 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.0 | 0.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.0 | 0.1 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.3 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.0 | 0.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.9 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.0 | 0.1 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.1 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.0 | 0.1 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.0 | 0.7 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.0 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.2 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.4 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.3 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.2 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.0 | 0.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.0 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.7 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 0.0 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.0 | 0.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.2 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.1 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.1 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.0 | 0.6 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.0 | 0.2 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.0 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.0 | 0.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.1 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.1 | GO:0045340 | mercury ion binding(GO:0045340) |
0.0 | 0.0 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.0 | 0.0 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.0 | 4.5 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.0 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.4 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.0 | 0.6 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.0 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.0 | 0.1 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.1 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.0 | 0.5 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.3 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.1 | GO:0005048 | signal sequence binding(GO:0005048) |
0.0 | 0.3 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.4 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.0 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.0 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.0 | 0.0 | GO:0015927 | trehalase activity(GO:0015927) |
0.0 | 0.0 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.0 | 0.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.1 | GO:0070728 | leucine binding(GO:0070728) |
0.0 | 0.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.0 | 0.0 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.0 | 0.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.5 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.4 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.1 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.0 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.3 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.0 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.0 | 0.1 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.2 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.0 | 0.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.0 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.0 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.0 | 0.1 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.0 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.0 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.0 | 0.1 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.0 | 0.0 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.2 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.1 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.0 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.2 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.0 | GO:1990188 | euchromatin binding(GO:1990188) |
0.0 | 5.4 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.0 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.0 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.0 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.0 | 0.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.1 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 3.6 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.4 | GO:0015631 | tubulin binding(GO:0015631) |
0.0 | 0.0 | GO:0019767 | IgE receptor activity(GO:0019767) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.3 | ST ADRENERGIC | Adrenergic Pathway |
0.3 | 18.9 | PID NOTCH PATHWAY | Notch signaling pathway |
0.3 | 9.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 4.5 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.3 | 7.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.3 | 7.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 3.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 3.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 2.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 1.1 | ST STAT3 PATHWAY | STAT3 Pathway |
0.2 | 0.4 | ST GAQ PATHWAY | G alpha q Pathway |
0.2 | 0.5 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 3.8 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 1.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 6.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 3.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 1.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.2 | 1.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 1.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 2.0 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 1.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.9 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 2.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 4.0 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 1.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 0.6 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 1.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 3.1 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 0.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 0.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 0.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 2.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 1.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 0.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 2.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.8 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 3.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 2.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 3.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 0.5 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.7 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 1.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 1.9 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 1.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 1.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 1.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 1.2 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 0.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 1.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 1.3 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 0.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 2.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 1.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.9 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 1.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 1.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.7 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 1.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 1.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.7 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 1.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 1.2 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.8 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.7 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.2 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.5 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 12.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.7 | 8.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.6 | 14.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.6 | 1.7 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.6 | 6.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.6 | 6.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.5 | 6.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.5 | 10.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.5 | 6.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.4 | 11.0 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.4 | 7.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.4 | 5.9 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.4 | 0.4 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.4 | 5.5 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.3 | 3.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.3 | 6.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.3 | 3.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.3 | 3.0 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.3 | 3.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.3 | 5.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 1.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.3 | 5.9 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.3 | 4.4 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.3 | 6.9 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.3 | 0.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.3 | 2.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.3 | 1.0 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.2 | 1.9 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 2.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.2 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.2 | 0.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 1.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 1.8 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.2 | 3.9 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.2 | 3.7 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 3.0 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.2 | 3.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.2 | 2.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 3.4 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.2 | 2.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 1.0 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.2 | 0.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.2 | 1.7 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.2 | 0.2 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.2 | 2.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 2.1 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.2 | 1.7 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 3.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.2 | 1.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.2 | 3.8 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.2 | 1.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 0.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 5.4 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.2 | 1.0 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.2 | 1.8 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.2 | 1.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 7.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 3.0 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 0.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.2 | 2.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 2.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 1.9 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 0.8 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 1.5 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 5.0 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 2.1 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 1.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 1.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 1.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 1.3 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 2.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.7 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 0.2 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 2.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 2.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 1.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 2.5 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 2.0 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 1.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 5.2 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
0.1 | 0.1 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.1 | 1.0 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 4.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 2.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 0.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 4.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 0.5 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 0.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 1.2 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 0.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.1 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 0.5 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.1 | 2.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 2.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 1.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.2 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 1.7 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 0.6 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.1 | 3.1 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 0.9 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 1.8 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 0.5 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 0.6 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 0.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 6.9 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 1.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 1.0 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.0 | 0.1 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.0 | 0.3 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 1.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.8 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 2.0 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.2 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.0 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.0 | 0.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 2.3 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 3.5 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.8 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.4 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.0 | 0.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 0.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.2 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.0 | 0.3 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.4 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.0 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 0.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.1 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.0 | 0.1 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.1 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |